분무 건조 생물학적 제제 시장 보고서(2026년)

Spray-dried biologics are biologic drugs that have been converted from a liquid into a dry powder through a rapid drying method. The process involves spraying the liquid formulation into heated air, which rapidly eliminates moisture while preserving the integrity of sensitive components such as proteins, vaccines, or enzymes. The resulting dry form provides benefits such as improved stability, easier handling, and compatibility with various delivery routes.

The primary product categories for spray-dried biologics encompass monoclonal antibodies, vaccines, enzymes, hormones, and additional types. Monoclonal antibodies consist of lab-engineered molecules that precisely identify and attach to particular target antigens. The various administration methods include oral, inhalation or pulmonary, injectable, and topical routes, which cater to end-users like hospitals, research institutes, pharmaceutical and biotechnology companies, and others.

Tariffs are influencing the spray-dried biologics market by increasing costs of imported spray dryers, stainless steel processing components, filtration systems, and analytical instruments used in biologic drug manufacturing. Pharmaceutical manufacturers in North America and Europe are most affected due to reliance on specialized imported equipment, while Asia-Pacific faces higher capital costs for facility expansion. These tariffs are raising production expenses and slowing capacity additions. At the same time, they are encouraging localized equipment manufacturing, regional supply partnerships, and investment in domestic biologics processing infrastructure.

The spray-dried biologics market research report is one of a series of new reports from The Business Research Company that provides spray-dried biologics market statistics, including spray-dried biologics industry global market size, regional shares, competitors with a spray-dried biologics market share, detailed spray-dried biologics market segments, market trends and opportunities, and any further data you may need to thrive in the spray-dried biologics industry. This spray-dried biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The spray-dried biologics market size has grown rapidly in recent years. It will grow from $1.86 billion in 2025 to $2.08 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to advancements in biologics formulation science, increasing biologic drug approvals, need for improved drug stability, expansion of vaccine manufacturing capacity, adoption of advanced pharmaceutical processing technologies.

The spray-dried biologics market size is expected to see rapid growth in the next few years. It will grow to $3.2 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing demand for non-injectable biologics, rising investments in dry powder delivery systems, expansion of global vaccine production, growing focus on cold-chain reduction, advancements in spray-drying equipment design. Major trends in the forecast period include increasing adoption of spray-drying for biologic stability, rising demand for inhalable and oral biologic formulations, expansion of continuous spray-drying processes, growing use of dry powder biologics in vaccines, enhanced focus on shelf-life extension.

Rising demand for biopharmaceuticals is anticipated to fuel expansion in the spray-dried biologics market. Biopharmaceuticals consist of therapeutic products sourced from biological origins, such as living cells, proteins, and various biomolecules. The need for biopharmaceuticals is growing amid a worldwide increase in chronic and complex diseases, heightening the demand for treatments with greater precision, enhanced effectiveness, and reduced systemic side effects. The spray-dried biologics sector is seeing heightened interest as the swift growth of biopharmaceuticals pushes firms toward scalable formulation methods that boost stability, extend shelf life, and optimize delivery. For example, in February 2025, the World Health Organization (WHO), a Switzerland-headquartered global public health body, reported that its 2023 essential medicines list (EML) featured 81 biologic therapies, representing over 15% of all essential medicines. Thus, the surging demand for biopharmaceuticals is propelling the spray-dried biologics market forward.

Major companies in the spray-dried biologics market are prioritizing technological innovations like drum dosing technology to boost dose precision, powder handling effectiveness, and dependable high-volume capsule filling. Drum dosing technology represents a sophisticated powder-filling technique that employs a rotating drum equipped with precisely designed dosing cavities and vacuum-assisted transfer to meter and place dry powders into capsules with high accuracy, supporting features such as uniform low-dose filling, better flow control for spray-dried powders, and scalable high-throughput operations. For example, in February 2024, Catalent Inc., a US-based contract development and manufacturing organization (CDMO), enhanced its inhalation manufacturing facility in the US by integrating potent capsule-filling capabilities driven by drum-based dosing systems and in-line advanced mass verification. The upgraded platform accommodates precise filling of engineered and spray-dried powders, incorporating real-time dose validation and controlled low-humidity processing. This improvement boosts manufacturing efficiency, product uniformity, and preparedness for commercial-scale production of spray-dried biologic dry-powder inhalation therapies.

In May 2023, Hovione, a Portugal-based integrated contract development and manufacturing organization (CDMO) focused on spray drying and particle engineering, teamed up with H&T Presspart to advance high-efficiency device technology for delivering dry powder inhalation formulations. This partnership allows Hovione to strengthen its expertise in engineered spray-dried and high-dose inhalation formulations by utilizing Presspart's Sunriser capsule-based dry powder inhaler platform, which boosts the performance and market readiness of inhalation therapies.

Major companies operating in the spray-dried biologics market are Thermo Fisher Scientific Inc., Evonik Industries AG, Lonza Group AG, GEA Group, Fareva Group, Almac Group Limited, Seqens Group, Fabbrica Italiana Sintetici S.p.A., CordenPharma International, Hovione FarmaCiencia SA, Veranova Inc., Pace Analytical Services LLC, Olon S.p.A., Nova Laboratories Ltd, Leukocare AG, Micro Sphere SA, Seran Bioscience LLC, CritiTech Particle Engineering Solutions LLC, Xedev BV, BUCHI Labortechnik AG.

North America was the largest region in the spray-dried biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spray-dried biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the spray-dried biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The spray-dried biologics market consists of sales of peptide therapeutics, deoxyribonucleic acid vaccines, ribonucleic acid vaccines, nanobodies, antibody-drug conjugates, and recombinant proteins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spray-Dried Biologics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses spray-dried biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for spray-dried biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The spray-dried biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Monoclonal Antibodies; Vaccines; Enzymes; Hormones; Other Product Types
• 2) By Route Of Administration: Oral; Inhalation Or Pulmonary; Injectable; Topical
• 3) By End-User: Hospitals; Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
• Subsegments:
• 1) By Monoclonal Antibodies: Chimeric Antibodies; Humanized Antibodies; Fully Human Antibodies; Bispecific Antibodies; Antibody Fragments
• 2) By Vaccines: Live Attenuated Vaccines; Inactivated Vaccines; Subunit Vaccines; Toxoid Vaccines; Viral Vector Vaccines; Recombinant Protein Vaccines
• 3) By Enzymes: Therapeutic Enzymes; Digestive Enzymes; Metabolic Enzymes; Recombinant Enzymes; Replacement Enzymes
• 4) By Hormones: Peptide Hormones; Protein Hormones; Steroid Hormones; Recombinant Hormones; Growth Hormones
• 5) By Other Product Types: Blood Factors; Cytokines; Fusion Proteins; Nucleic Acid Therapeutics; Cell Culture Media Proteins
• Companies Mentioned: Thermo Fisher Scientific Inc.; Evonik Industries AG; Lonza Group AG; GEA Group; Fareva Group; Almac Group Limited; Seqens Group; Fabbrica Italiana Sintetici S.p.A.; CordenPharma International; Hovione FarmaCiencia SA; Veranova Inc.; Pace Analytical Services LLC; Olon S.p.A.; Nova Laboratories Ltd; Leukocare AG; Micro Sphere SA; Seran Bioscience LLC; CritiTech Particle Engineering Solutions LLC; Xedev BV; BUCHI Labortechnik AG.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Spray-Dried Biologics Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Spray-Dried Biologics Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Spray-Dried Biologics Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Spray-Dried Biologics Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Sustainability, Climate Tech & Circular Economy
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Spray-Drying For Biologic Stability
  • 4.2.2 Rising Demand For Inhalable And Oral Biologic Formulations
  • 4.2.3 Expansion Of Continuous Spray-Drying Processes
  • 4.2.4 Growing Use Of Dry Powder Biologics In Vaccines
  • 4.2.5 Enhanced Focus On Shelf-Life Extension

5. Spray-Dried Biologics Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Research Institutes
• 5.3 Pharmaceutical Companies
• 5.4 Biotechnology Companies
• 5.5 Contract Manufacturing Organizations

6. Spray-Dried Biologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Spray-Dried Biologics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Spray-Dried Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Spray-Dried Biologics Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Spray-Dried Biologics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Spray-Dried Biologics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Spray-Dried Biologics Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Spray-Dried Biologics Market Segmentation

• 9.1. Global Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Monoclonal Antibodies, Vaccines, Enzymes, Hormones, Other Product Types
• 9.2. Global Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Inhalation Or Pulmonary, Injectable, Topical
• 9.3. Global Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
• 9.4. Global Spray-Dried Biologics Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Chimeric Antibodies, Humanized Antibodies, Fully Human Antibodies, Bispecific Antibodies, Antibody Fragments
• 9.5. Global Spray-Dried Biologics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Viral Vector Vaccines, Recombinant Protein Vaccines
• 9.6. Global Spray-Dried Biologics Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Therapeutic Enzymes, Digestive Enzymes, Metabolic Enzymes, Recombinant Enzymes, Replacement Enzymes
• 9.7. Global Spray-Dried Biologics Market, Sub-Segmentation Of Hormones, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Peptide Hormones, Protein Hormones, Steroid Hormones, Recombinant Hormones, Growth Hormones
• 9.8. Global Spray-Dried Biologics Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Blood Factors, Cytokines, Fusion Proteins, Nucleic Acid Therapeutics, Cell Culture Media Proteins

10. Spray-Dried Biologics Market Regional And Country Analysis

• 10.1. Global Spray-Dried Biologics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Spray-Dried Biologics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Spray-Dried Biologics Market

• 11.1. Asia-Pacific Spray-Dried Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Spray-Dried Biologics Market

• 12.1. China Spray-Dried Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Spray-Dried Biologics Market

• 13.1. India Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Spray-Dried Biologics Market

• 14.1. Japan Spray-Dried Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Spray-Dried Biologics Market

• 15.1. Australia Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Spray-Dried Biologics Market

• 16.1. Indonesia Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Spray-Dried Biologics Market

• 17.1. South Korea Spray-Dried Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Spray-Dried Biologics Market

• 18.1. Taiwan Spray-Dried Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Spray-Dried Biologics Market

• 19.1. South East Asia Spray-Dried Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Spray-Dried Biologics Market

• 20.1. Western Europe Spray-Dried Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Spray-Dried Biologics Market

• 21.1. UK Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Spray-Dried Biologics Market

• 22.1. Germany Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Spray-Dried Biologics Market

• 23.1. France Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Spray-Dried Biologics Market

• 24.1. Italy Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Spray-Dried Biologics Market

• 25.1. Spain Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Spray-Dried Biologics Market

• 26.1. Eastern Europe Spray-Dried Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Spray-Dried Biologics Market

• 27.1. Russia Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Spray-Dried Biologics Market

• 28.1. North America Spray-Dried Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Spray-Dried Biologics Market

• 29.1. USA Spray-Dried Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Spray-Dried Biologics Market

• 30.1. Canada Spray-Dried Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Spray-Dried Biologics Market

• 31.1. South America Spray-Dried Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Spray-Dried Biologics Market

• 32.1. Brazil Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Spray-Dried Biologics Market

• 33.1. Middle East Spray-Dried Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Spray-Dried Biologics Market

• 34.1. Africa Spray-Dried Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Spray-Dried Biologics Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Spray-Dried Biologics Market Regulatory and Investment Landscape

36. Spray-Dried Biologics Market Competitive Landscape And Company Profiles

• 36.1. Spray-Dried Biologics Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Spray-Dried Biologics Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Spray-Dried Biologics Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. GEA Group Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Fareva Group Overview, Products and Services, Strategy and Financial Analysis

37. Spray-Dried Biologics Market Other Major And Innovative Companies

• Almac Group Limited, Seqens Group, Fabbrica Italiana Sintetici S.p.A., CordenPharma International, Hovione FarmaCiencia SA, Veranova Inc., Pace Analytical Services LLC, Olon S.p.A., Nova Laboratories Ltd, Leukocare AG, Micro Sphere SA, Seran Bioscience LLC, CritiTech Particle Engineering Solutions LLC, Xedev BV, BUCHI Labortechnik AG

38. Global Spray-Dried Biologics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Spray-Dried Biologics Market

40. Spray-Dried Biologics Market High Potential Countries, Segments and Strategies

• 40.1 Spray-Dried Biologics Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Spray-Dried Biologics Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Spray-Dried Biologics Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer